Lumbar puncture (LP) is an essential and very common medical procedure. It can give rise to adverse events, which are rarely serious, but the incidence of which can be reduced by applying simple measures.
Post-lumbar puncture syndrome (PLPS) is the most frequent adverse event. Secondary to a persistent leak of cerebrospinal fluid (CSF), it manifests itself as an orthostatic headache, usually appearing 2 to 4 days after the procedure.
Invented in 1979, the result of a collaboration between Pajunk® and Professor Sprotte, the Sprotte® needle is the first atraumatic needle for lumbar puncture.
The secret of its success lies in the unique geometry of its tip and the architecture of its base.
This design, developed specifically for lumbar puncture, enables atraumatic puncture of the various membranes and optimises cerebrospinal fluid (CSF) reflux while reducing the incidence of post dural puncture headaches (PDPH).
Prof. Günter Sprotte
The Sprotte® needle guarantees patients and users functionality, safety and reliability, as well as a reduction in the incidence of post dural puncture headaches.
The HAS published recommendations in June 2019 for “the prevention and management of adverse events that may occur after lumbar puncture”.
Atraumatic needles for lumbar puncture are covered by the new NRFit® standard.
Pajunk’s atraumatic Sprotte® needles are all available with this new NRFit® connector.